Disseminated histoplasmosis in pediatric kidney transplant recipients—A report of six cases and review of the literature

Kenice Ferguson-Paul, Catherine Park, Sandra Childress, Sandra Arnold, Bettina Ault, Bindiya Bagga

Research output: Contribution to journalArticle

Abstract

Background: We report a case series of histoplasmosis in KTx patients in a children's hospital in an endemic area. Methods: All KTx cases from January 1, 2002, to August 31, 2016, were reviewed to identify those with disseminated histoplasmosis. Results: The attack rate of histoplasmosis among our KTx patients was 6.9 per 100 cases. The median age at the time of diagnosis was 16 years (11-18). Comorbidities included glomerulosclerosis (3), medullary cystic disease (1), and obstructive uropathy (2) and HIV (1). There were 5 deceased and 1 living-related donor transplants, and no patient had a history of rejection prior to histoplasmosis. Median time from transplant to histoplasmosis was 14.8 months (IQR 2.2-38.3) and 33% occurred in the first year after transplant. Urine and/or serum antigens were positive in all patients. They were either treated with amphotericin B and transitioned to an azole or received azole monotherapy. Most (83%) received chronic suppression with itraconazole. No patients died and relapse occurred in 1 patient after repeat transplant. Conclusions: KTx patients in endemic areas are at risk for disseminated histoplasmosis. Further study is needed to determine which factors portend the need for fungal prophylaxis in this subset of patients.

Original languageEnglish (US)
Article numbere13274
JournalPediatric Transplantation
Volume22
Issue number7
DOIs
StatePublished - Nov 1 2018

Fingerprint

Histoplasmosis
Pediatrics
Transplants
Kidney
Azoles
Itraconazole
Living Donors
Amphotericin B
HIV-1
Comorbidity
Urine
Antigens
Recurrence

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Disseminated histoplasmosis in pediatric kidney transplant recipients—A report of six cases and review of the literature. / Ferguson-Paul, Kenice; Park, Catherine; Childress, Sandra; Arnold, Sandra; Ault, Bettina; Bagga, Bindiya.

In: Pediatric Transplantation, Vol. 22, No. 7, e13274, 01.11.2018.

Research output: Contribution to journalArticle

Ferguson-Paul, Kenice ; Park, Catherine ; Childress, Sandra ; Arnold, Sandra ; Ault, Bettina ; Bagga, Bindiya. / Disseminated histoplasmosis in pediatric kidney transplant recipients—A report of six cases and review of the literature. In: Pediatric Transplantation. 2018 ; Vol. 22, No. 7.
@article{346f630fa1184097a96681a9170764a3,
title = "Disseminated histoplasmosis in pediatric kidney transplant recipients—A report of six cases and review of the literature",
abstract = "Background: We report a case series of histoplasmosis in KTx patients in a children's hospital in an endemic area. Methods: All KTx cases from January 1, 2002, to August 31, 2016, were reviewed to identify those with disseminated histoplasmosis. Results: The attack rate of histoplasmosis among our KTx patients was 6.9 per 100 cases. The median age at the time of diagnosis was 16 years (11-18). Comorbidities included glomerulosclerosis (3), medullary cystic disease (1), and obstructive uropathy (2) and HIV (1). There were 5 deceased and 1 living-related donor transplants, and no patient had a history of rejection prior to histoplasmosis. Median time from transplant to histoplasmosis was 14.8 months (IQR 2.2-38.3) and 33{\%} occurred in the first year after transplant. Urine and/or serum antigens were positive in all patients. They were either treated with amphotericin B and transitioned to an azole or received azole monotherapy. Most (83{\%}) received chronic suppression with itraconazole. No patients died and relapse occurred in 1 patient after repeat transplant. Conclusions: KTx patients in endemic areas are at risk for disseminated histoplasmosis. Further study is needed to determine which factors portend the need for fungal prophylaxis in this subset of patients.",
author = "Kenice Ferguson-Paul and Catherine Park and Sandra Childress and Sandra Arnold and Bettina Ault and Bindiya Bagga",
year = "2018",
month = "11",
day = "1",
doi = "10.1111/petr.13274",
language = "English (US)",
volume = "22",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Disseminated histoplasmosis in pediatric kidney transplant recipients—A report of six cases and review of the literature

AU - Ferguson-Paul, Kenice

AU - Park, Catherine

AU - Childress, Sandra

AU - Arnold, Sandra

AU - Ault, Bettina

AU - Bagga, Bindiya

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Background: We report a case series of histoplasmosis in KTx patients in a children's hospital in an endemic area. Methods: All KTx cases from January 1, 2002, to August 31, 2016, were reviewed to identify those with disseminated histoplasmosis. Results: The attack rate of histoplasmosis among our KTx patients was 6.9 per 100 cases. The median age at the time of diagnosis was 16 years (11-18). Comorbidities included glomerulosclerosis (3), medullary cystic disease (1), and obstructive uropathy (2) and HIV (1). There were 5 deceased and 1 living-related donor transplants, and no patient had a history of rejection prior to histoplasmosis. Median time from transplant to histoplasmosis was 14.8 months (IQR 2.2-38.3) and 33% occurred in the first year after transplant. Urine and/or serum antigens were positive in all patients. They were either treated with amphotericin B and transitioned to an azole or received azole monotherapy. Most (83%) received chronic suppression with itraconazole. No patients died and relapse occurred in 1 patient after repeat transplant. Conclusions: KTx patients in endemic areas are at risk for disseminated histoplasmosis. Further study is needed to determine which factors portend the need for fungal prophylaxis in this subset of patients.

AB - Background: We report a case series of histoplasmosis in KTx patients in a children's hospital in an endemic area. Methods: All KTx cases from January 1, 2002, to August 31, 2016, were reviewed to identify those with disseminated histoplasmosis. Results: The attack rate of histoplasmosis among our KTx patients was 6.9 per 100 cases. The median age at the time of diagnosis was 16 years (11-18). Comorbidities included glomerulosclerosis (3), medullary cystic disease (1), and obstructive uropathy (2) and HIV (1). There were 5 deceased and 1 living-related donor transplants, and no patient had a history of rejection prior to histoplasmosis. Median time from transplant to histoplasmosis was 14.8 months (IQR 2.2-38.3) and 33% occurred in the first year after transplant. Urine and/or serum antigens were positive in all patients. They were either treated with amphotericin B and transitioned to an azole or received azole monotherapy. Most (83%) received chronic suppression with itraconazole. No patients died and relapse occurred in 1 patient after repeat transplant. Conclusions: KTx patients in endemic areas are at risk for disseminated histoplasmosis. Further study is needed to determine which factors portend the need for fungal prophylaxis in this subset of patients.

UR - http://www.scopus.com/inward/record.url?scp=85052650824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052650824&partnerID=8YFLogxK

U2 - 10.1111/petr.13274

DO - 10.1111/petr.13274

M3 - Article

VL - 22

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 7

M1 - e13274

ER -